Taken together, these findings suggest that elevated CHI3L1 levels are more closely associated with long‐term cognitive impairment than with general functional disability, supporting the potential of CHI3L1 as a clinically meaningful biomarker for predicting cognitive outcomes in pediatric anti‐NMDAR encephalitis. The gene discussed is CHI3L1; the disease is Cognitive impairment.